Theriva Biologics Stock Price History

TOVX Stock  USD 1.34  0.06  4.69%   
Below is the normalized historical share price chart for Theriva Biologics extending back to January 14, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Theriva Biologics stands at 1.34, as last reported on the 27th of November, with the highest price reaching 1.39 and the lowest price hitting 1.29 during the day.
IPO Date
18th of December 2006
200 Day MA
6.5973
50 Day MA
1.8242
Beta
1.338
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Theriva Stock, it is important to understand the factors that can impact its price. Theriva Biologics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0926, which indicates the firm had a -0.0926% return per unit of risk over the last 3 months. Theriva Biologics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Theriva Biologics' Risk Adjusted Performance of (0.03), variance of 175.27, and Coefficient Of Variation of (2,205) to confirm the risk estimate we provide.
  
At this time, Theriva Biologics' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 58 M in 2024, whereas Common Stock is likely to drop slightly above 17.1 K in 2024. . Price To Sales Ratio is likely to drop to 241.35 in 2024. Price Earnings Ratio is likely to drop to -0.4 in 2024. Theriva Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0926

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsTOVX

Estimated Market Risk

 12.7
  actual daily
96
96% of assets are less volatile

Expected Return

 -1.18
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.09
  actual daily
0
Most of other assets perform better
Based on monthly moving average Theriva Biologics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Theriva Biologics by adding Theriva Biologics to a well-diversified portfolio.
Price Book
0.1446
Book Value
53.888
Enterprise Value
-11.1 M
Enterprise Value Ebitda
1.7192
Shares Float
658.8 K

Theriva Biologics Stock Price History Chart

There are several ways to analyze Theriva Stock price data. The simplest method is using a basic Theriva candlestick price chart, which shows Theriva Biologics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceSeptember 6, 20244.37
Lowest PriceOctober 2, 20241.24

Theriva Biologics November 27, 2024 Stock Price Synopsis

Various analyses of Theriva Biologics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Theriva Stock. It can be used to describe the percentage change in the price of Theriva Biologics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Theriva Stock.
Theriva Biologics Price Rate Of Daily Change 1.05 
Theriva Biologics Price Action Indicator 0.03 
Theriva Biologics Price Daily Balance Of Power 0.60 
Theriva Biologics Accumulation Distribution 6,748 

Theriva Biologics November 27, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Theriva Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Theriva Biologics intraday prices and daily technical indicators to check the level of noise trading in Theriva Stock and then apply it to test your longer-term investment strategies against Theriva.

Theriva Stock Price History Data

The price series of Theriva Biologics for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 has a statistical range of 4.66 with a coefficient of variation of 50.62. The price distribution for the period has arithmetic mean of 2.3. The median price for the last 90 days is 1.65. The company completed stock split (1:25) on 26th of August 2024. Theriva Biologics had dividends distributed to its stock-holders on 2018-08-13.
OpenHighLowCloseVolume
11/27/2024 1.29  1.39  1.29  1.34  93,796 
11/26/2024 1.28  1.30  1.27  1.28  38,237 
11/25/2024 1.29  1.32  1.26  1.30  74,574 
11/22/2024 1.30  1.32  1.27  1.28  49,217 
11/21/2024 1.28  1.32  1.23  1.28  53,188 
11/20/2024 1.29  1.32  1.25  1.26  60,100 
11/19/2024 1.24  1.31  1.22  1.26  112,480 
11/18/2024 1.41  1.43  1.24  1.24  180,725 
11/15/2024 1.34  1.41  1.34  1.36  85,137 
11/14/2024 1.41  1.44  1.31  1.35  153,938 
11/13/2024 1.45  1.53  1.37  1.42  190,355 
11/12/2024 1.79  1.80  1.40  1.43  621,606 
11/11/2024 2.07  2.07  1.83  1.86  238,148 
11/08/2024 2.17  2.19  1.98  1.99  254,992 
11/07/2024 1.98  2.22  1.98  2.16  625,229 
11/06/2024 1.88  2.07  1.88  1.97  460,363 
11/05/2024 1.99  2.13  1.95  1.97  990,373 
11/04/2024 1.89  2.08  1.75  2.07  2,009,329 
11/01/2024 2.19  2.64  1.76  1.99  85,124,976 
10/31/2024 1.50  1.52  1.40  1.46  42,651 
10/30/2024 1.47  1.52  1.47  1.48  99,304 
10/29/2024 1.51  1.54  1.43  1.47  55,653 
10/28/2024 1.57  1.57  1.49  1.52  77,573 
10/25/2024 1.46  1.57  1.46  1.53  130,163 
10/24/2024 1.46  1.55  1.46  1.50  132,314 
10/23/2024 1.49  1.50  1.41  1.47  50,940 
10/22/2024 1.49  1.49  1.43  1.45  61,300 
10/21/2024 1.48  1.51  1.47  1.48  67,338 
10/18/2024 1.49  1.52  1.43  1.49  134,785 
10/17/2024 1.44  1.47  1.40  1.45  99,354 
10/16/2024 1.40  1.47  1.37  1.46  407,994 
10/15/2024 1.41  1.44  1.32  1.39  100,200 
10/14/2024 1.50  1.53  1.37  1.39  166,333 
10/11/2024 1.56  1.57  1.49  1.51  197,360 
10/10/2024 1.58  1.62  1.55  1.56  199,927 
10/09/2024 1.52  1.75  1.51  1.65  400,832 
10/08/2024 1.64  1.64  1.50  1.54  362,828 
10/07/2024 1.64  1.73  1.50  1.63  624,500 
10/04/2024 1.76  1.76  1.48  1.68  1,222,071 
10/03/2024 1.85  1.93  1.51  1.79  76,402,596 
10/02/2024 1.28  1.29  1.24  1.24  89,613 
10/01/2024 1.35  1.37  1.24  1.28  172,350 
09/30/2024 1.40  1.48  1.32  1.38  304,974 
09/27/2024 1.69  1.76  1.44  1.49  1,826,508 
09/26/2024 2.30  2.30  1.79  2.04  1,731,198 
09/25/2024 3.24  3.25  2.36  2.37  358,178 
09/24/2024 3.44  3.71  3.26  3.26  47,609 
09/23/2024 3.72  3.80  3.40  3.42  136,717 
09/20/2024 3.61  4.03  3.61  3.80  146,307 
09/19/2024 3.95  4.04  3.59  3.79  125,585 
09/18/2024 4.10  4.10  3.90  3.95  23,153 
09/17/2024 3.88  4.20  3.80  4.10  109,739 
09/16/2024 3.98  4.29  3.77  3.85  134,319 
09/13/2024 3.78  4.19  3.76  4.06  216,877 
09/12/2024 3.81  3.89  3.50  3.60  65,443 
09/11/2024 3.01  4.20  3.01  3.89  135,767 
09/10/2024 4.13  4.48  3.76  3.88  88,401 
09/09/2024 3.82  4.53  3.75  4.16  209,111 
09/06/2024 3.17  4.95  3.16  4.37  949,184 
09/05/2024 3.01  3.72  3.01  3.22  413,323 
09/04/2024 3.81  3.93  3.09  3.10  365,460 

About Theriva Biologics Stock history

Theriva Biologics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Theriva is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Theriva Biologics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Theriva Biologics stock prices may prove useful in developing a viable investing in Theriva Biologics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding644.3 K1.1 M
Net Loss-22.6 M-23.8 M

Theriva Biologics Quarterly Net Working Capital

12.21 Million

Theriva Biologics Stock Technical Analysis

Theriva Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Theriva Biologics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Theriva Biologics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Top Crypto Exchanges Now

   

Top Crypto Exchanges

Search and analyze digital assets across top global cryptocurrency exchanges
All  Next Launch Module

Theriva Biologics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Theriva Biologics' price direction in advance. Along with the technical and fundamental analysis of Theriva Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Theriva to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Theriva Stock Analysis

When running Theriva Biologics' price analysis, check to measure Theriva Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theriva Biologics is operating at the current time. Most of Theriva Biologics' value examination focuses on studying past and present price action to predict the probability of Theriva Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theriva Biologics' price. Additionally, you may evaluate how the addition of Theriva Biologics to your portfolios can decrease your overall portfolio volatility.